Press Release – New York, NY – August 28, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented Sharps Technology, Inc. (Nasdaq: STSS and STSSW), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, in its recently priced $400 million private placement to support its plans to adopt a digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain.
The SRFC team was led by partners Gregory Sichenzia and Arthur Marcus, with associate Jesse Blue.
